Earnings per share for the last twelve months: DarioHealth Corp (DRIO)

DRIO (DarioHealth Corp) - company brandmark

DarioHealth Corp. possesses strong pricing power driven by its AI-powered hypertension and diabetes management system. A snapshot of the rolling net income per share visualizes these processes, with the indicator value reaching -5.17. The company generates revenue through subscriptions from insurers and patients. Business scaling via corporate contracts is currently constrained only by marketing expenses and software integration costs.

DRIO (DarioHealth Corp.) Net earnings per share for the last four quarters history from 07/04/2022 to 11/15/2026

Analytical breakdowns for DarioHealth Corporation (DRIO)

- stock price and consensus target price:
Stock Price mydario.com|DRIO - Analyst Consensus Forecast
- company stock exchange capitalization indicators:
Market Value DarioHealth Inc|DRIO - Value Adjusted for Debt and Cash
- shareholders' equity book value data:
Book Value per Share DarioHealth|DRIO - Book Valuation of Business|Market Value to Book Value Ratio mydario.com|DRIO - Company Assets
- debt obligations and liquidity statistics:
Total Debt to Capital DarioHealth Corp.|DRIO - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital DarioHealth Corp|DRIO - Company Cumulative Debt|Debts to Book Capitalization DarioHealth Corp|DRIO - Company Long-Term Debts|Company Short-Term Debt DarioHealth|Quick Liquidity Indicator mydario.com
- net income and valuation multiples indicators:
DRIO - Profit After Payment of Taxes|Projected Future Earnings DarioHealth Corp.|DRIO - Company Value to Net Income|Projected Price to Earnings DarioHealth Corporation|DRIO - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple DarioHealth Inc|DRIO - Operating profit before deduction of amortization|Earnings per share for the last twelve months DarioHealth|DRIO - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months mydario.com|DRIO - Earnings per share increase in current year|Net earnings per share growth forecast for next year DarioHealth Corp.
- total revenue and sales volume data:
DRIO - Company Annual Revenue|Company Future Sales Volume DarioHealth Corp|DRIO - Price-to-Revenue Coefficient|Forward P/S Multiple DarioHealth|DRIO - Sales Growth YoY (Last 12 Months)
Basic company analysis:mydario.com (DRIO)
Manufactured products of DarioHealth Corp

DarioHealth Corp. (DRIO) is scaling its digital platform, overcoming temporary integration costs within the insurance sector. The TTM EPS reflects net income allocated per share over a rolling year. This metric allows for an assessment of real capital efficiency net of all expenses. Growth in earnings per share confirms the operational leverage of the software. By analyzing the EPS trend over the last 12 months, an investor can identify the gap between the asset's value and its yield.

Competitors of DarioHealth Corp. (DRIO)

Hims & Hers Health, Inc. - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Hinge Health, Inc. HNGE|Teladoc Inc. (TDOC) - Earnings per share for the last twelve months|TALK (Talkspace Platform) - Earnings per share for the last twelve months|LFMD (LifeMD Inc.) - Net earnings per share (EPS TTM)|AMWL: Earnings per share for the trailing year|Earnings per share for the last twelve months Mangoceuticals, Inc. (MGRX)|VSEE (VSee Health) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) MNDR (manadr.com)|Net earnings per share (EPS TTM) Accolade Health ACCD|biotricity.com - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Lytus Technologies|OTRK: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months SHL Telemedicine, Ltd. (SHLT)|THRN (thorne.com) - Net earnings per share (EPS TTM)